Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J McAuliffe

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Seminars in Liver Disease|February 1, 1981
Hepatitis B vaccines: present statusS Krugman, V J McAuliffe, R H Purcell
Lancet (London, England)|October 27, 1973
Letter: biological activity of hepatitis-B-antigen soluble immune complexesV J McAuliffe, Z I Kachani, D J Gocke
Reviews of Infectious Diseases|May 1, 1980
Type B hepatitis: a review of current prospects for a safe and effective vaccineV J McAuliffe, R H Purcell, J L Gerin
The New England Journal of Medicine|April 1, 1976
Editorial: e: a third hepatitis B antigen?V J McAuliffe, R H Purcell, G L Le Bouvier
The Journal of Infectious Diseases|August 1, 1983
IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccineG Y Minuk, J H Hoofnagle, V J McAuliffe, et al.
The Journal of General Virology|March 1, 1978
Antigens of hepatitis B virus: failure to detect HBeAg on the surfaces of HBsAg formsJ L Gerin, J Wai-Kuo Shih, V J McAuliffe, et al.
Journal of Virology|March 1, 1981
Proteins of Norwalk virusH B Greenberg, J R Valdesuso, A R Kalica, et al.
Infection and Immunity|June 1, 1977
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semenH J Alter, R H Purcell, J L Gerin, et al.
The New England Journal of Medicine|October 21, 1976
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposureH J Alter, L B Seeff, P M Kaplan, et al.
The New England Journal of Medicine|March 19, 1992
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study GroupW G Powderly, M S Saag, G A Cloud, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Seminars in Liver Disease|February 1, 1981
Hepatitis B vaccines: present statusS Krugman, V J McAuliffe, R H Purcell
Lancet (London, England)|October 27, 1973
Letter: biological activity of hepatitis-B-antigen soluble immune complexesV J McAuliffe, Z I Kachani, D J Gocke
Reviews of Infectious Diseases|May 1, 1980
Type B hepatitis: a review of current prospects for a safe and effective vaccineV J McAuliffe, R H Purcell, J L Gerin
The New England Journal of Medicine|April 1, 1976
Editorial: e: a third hepatitis B antigen?V J McAuliffe, R H Purcell, G L Le Bouvier
The Journal of Infectious Diseases|August 1, 1983
IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccineG Y Minuk, J H Hoofnagle, V J McAuliffe, et al.
The Journal of General Virology|March 1, 1978
Antigens of hepatitis B virus: failure to detect HBeAg on the surfaces of HBsAg formsJ L Gerin, J Wai-Kuo Shih, V J McAuliffe, et al.
Journal of Virology|March 1, 1981
Proteins of Norwalk virusH B Greenberg, J R Valdesuso, A R Kalica, et al.
Infection and Immunity|June 1, 1977
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semenH J Alter, R H Purcell, J L Gerin, et al.
The New England Journal of Medicine|October 21, 1976
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposureH J Alter, L B Seeff, P M Kaplan, et al.
The New England Journal of Medicine|March 19, 1992
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study GroupW G Powderly, M S Saag, G A Cloud, et al.
Pageof 2